{"title":"네이버 금융 ─ 뉴스 ─ 기업 종목분석","url":"https://finance.naver.com/news/news_list.naver?mode=LSS3D&section_id=101&section_id2=258&section_id3=402","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"삼성증권, '투자스쿨' 가입자 개인정보 외부 노출…\"유출 흔적 없어\"","contents":"<a href=\"/news/news_read.naver?article_id=0004629574&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211117&amp;page=1\" title=\"삼성증권, '투자스쿨' 가입자 개인정보 외부 노출…&quot;유출 흔적 없어&quot;\">삼성증권, '투자스쿨' 가입자 개인정보 외부 노출…\"유출 흔적 없어\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004629574&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211117&page=1","retrieved":1637125466185},{"title":"한미약품 \"세계 최초 'CCR4' 면역항암제…종양 58% 감소 확인\"","contents":"<a href=\"/news/news_read.naver?article_id=0004629572&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211117&amp;page=1\" title=\"한미약품 &quot;세계 최초 'CCR4' 면역항암제…종양 58% 감소 확인&quot;\">한미약품 \"세계 최초 'CCR4' 면역항암제…종양 58% 감소 확인\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004629572&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211117&page=1","retrieved":1637125466186},{"title":"올 4분기 '어닝 쇼크'를 피하라","contents":"<a href=\"/news/news_read.naver?article_id=0005000961&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211117&amp;page=1\" title=\"올 4분기 '어닝 쇼크'를 피하라\">올 4분기 '어닝 쇼크'를 피하라</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005000961&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211117&page=1","retrieved":1637118304729},{"title":"[공장탐방]쓰리메디비젼, '메타버스 수의교육 플랫폼' 글로벌시장 도전장","contents":"<a href=\"/news/news_read.naver?article_id=0005000950&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211117&amp;page=1\" title=\"[공장탐방]쓰리메디비젼, '메타버스 수의교육 플랫폼' 글로벌시장 도전장\">[공장탐방]쓰리메디비젼, '메타버스 수의교육 플랫폼' 글로벌시장 도전장</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005000950&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211117&page=1","retrieved":1637118304729},{"title":"금값 뛰자 금펀드 수익률 '번쩍'","contents":"<a href=\"/news/news_read.naver?article_id=0005000946&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211117&amp;page=1\" title=\"금값 뛰자 금펀드 수익률 '번쩍'\">금값 뛰자 금펀드 수익률 '번쩍'</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005000946&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211117&page=1","retrieved":1637118304732},{"title":"삼양홀딩스 바이오팜그룹, 안면성형 실 '크로키' 英 수출","contents":"<a href=\"/news/news_read.naver?article_id=0004629542&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211117&amp;page=1\" title=\"삼양홀딩스 바이오팜그룹, 안면성형 실 '크로키' 英 수출\">삼양홀딩스 바이오팜그룹, 안면성형 실 '크로키' 英 수출</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004629542&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211117&page=1","retrieved":1637118304734},{"title":"삼성증권, 투자자교육사이트 이용자 정보 노출 우려 공지","contents":"<a href=\"/news/news_read.naver?article_id=0004741170&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211117&amp;page=1\" title=\"삼성증권, 투자자교육사이트 이용자 정보 노출 우려 공지\">삼성증권, 투자자교육사이트 이용자 정보 노출 우려 공지</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004741170&office_id=014&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211117&page=1","retrieved":1637118304736}]}